MoonLake Immunotherapeutics (MLTX) earnings date
Mar 1, 2027, before open estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 45% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 41 days, typically, give or take 8 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Wed, Nov 4, 2026 | before open | 35 | 8-K |
| Q2 FY2026 | Mon, Aug 10, 2026 | before open | 41 | 8-K |
| Q1 FY2026 | Mon, May 11, 2026 | before open | 41 | 8-K |
| Q4 FY2025 | Mon, Feb 23, 2026 | before open | 54 | 8-K |
| Q3 FY2025 | Wed, Nov 5, 2025 | before open | 36 | 8-K |
| Q2 FY2025 | Tue, Aug 5, 2025 | before open | 36 | 8-K |
| Q1 FY2025 | Mon, May 12, 2025 | after close | 42 | 8-K |
| Q4 FY2024 | Wed, Feb 26, 2025 | before open | 57 | 8-K |
What they guided beta
| Q3 FY2026 | "Enrollment completed in the Phase 3 IZAR-2 trial in psoriatic arthritis, with initial topline results expected in Q1 2027 following the predefined unblinding protocol" exhibit |
| Q3 FY2026 | "Phase 3 NOVA trial in palmoplantar pustulosis on track to start enrollment in November 2026" exhibit |
| Q3 FY2026 | "MoonLake ended the third quarter with $498.5 million in cash, cash equivalents and short-term marketable debt securities and expects to have a cash runway to mid-2028; additionally, up to $400 million in non-dilutive funds remain available through its debt facility with Hercules Capital ZUG, Switzerland, November 4, 2026 – MoonLake Immunotherapeutics (NASDAQ: MLTX) ("MoonLake" or the "Company"), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, today provided a business update and reported third quarter 2026 financial results." exhibit |
| Q3 FY2026 | "The Company expects to complete the VELA-TEEN clinical trial in the fourth quarter of 2026 and plans to submit final results for presentation at a scientific conference in the first quarter of 2027." exhibit |
| Q3 FY2026 | "The Company expects to announce initial topline results following a predefined unblinding protocol in the first quarter of 2027." exhibit |
| Q2 FY2026 | "The IZAR-1 trial remains blinded and will continue until Week 52 with MoonLake expecting the full readout in H1 2027 whereas the IZAR-2 trial (a trial in TNF-refractory patients) is expected to complete enrollment in Q3 2026" exhibit |
| Q2 FY2026 | "MoonLake ended the second quarter with $537.0 million in cash, cash equivalents and short-term marketable debt securities and expects to have a cash runway to mid-2028; additionally, up to $400 million in non-dilutive funds remain available through its debt facility with Hercules Capital" exhibit |
| Q2 FY2026 | "The Company expects to have sufficient capital to fund its operating expenses and capital expenditure requirements to mid-2028." exhibit |
| Q2 FY2026 | "o End Sep. 2026: Expected submission of Biologics License Application (BLA)" exhibit |
| Q2 FY2026 | "o End Nov. 2026: Expected to receive Prescription Drug User Fee Act (PDUFA) date allocation and decision on Priority Review" exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/MLTX
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/MLTX
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/MLTX/"><img src="https://veritasdata.dev/embed/MLTX.svg" alt="MLTX earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/MLTX/)
Script
<script async src="https://veritasdata.dev/embed/MLTX.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/MLTX"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.